Feasibility study for the use of gene electrotransfer and cell electrofusion as a single-step technique for the generation of activated cancer cell vaccines
Preprint in Research Square (April 2024)
The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.
A SARS-CoV-2 RBD vaccine fused to the chemokine MIP-3α elicits sustained murine antibody responses over 12 months and enhanced lung T-cell responses
Article in Frontiers in Immunology (February 2024)
Advances, opportunities and challenges in developing therapeutic cancer vaccines
Article in Critical Reviews in Oncology/Hematology (November 2023)